Endologix AFX Endovascular AAA System Instructions for Use Updated
Endologix updated the Instructions for Use and modified the AFX Endovascular AAA System. The correction applies to procedures conducted after July 2015.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall involves an FDA Class II classification with no reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Endologix has updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular AAA System. This system is intended for the endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (AAA).
The correction is not lot specific and applies to AFX procedures conducted after July 2015. The product was distributed nationwide in the United States and internationally to Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Israel, Italy, Latvia, Luxembourg, Monaco, Netherlands, Poland, Portugal, Spain, Sweden, Switzerland, Turkey, and the United Kingdom.
Healthcare providers should review the updated Instructions for Use and modifications to the AFX Endovascular AAA System. Patients who have had this procedure should consult their healthcare provider for specific guidance regarding the update.
The recalled product
- Product
- AFX Endovascular AAA System, Endoleak Type IIIA Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdomin
- Manufacturer
- Endologix
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Endologix
See all →- HighEndologix AFX Endovascular AAA System Recall for Type III Endoleaks
FDA (Devices) · 2018-10-10
- HighEndologix AFX2 Bifurcated Endograft System Recall for Type III Endoleaks
FDA (Devices) · 2018-10-10
- HighEndologix AFX Endograft Recall for Type III Endoleak Surveillance
FDA (Devices) · 2018-10-10
- HighEndologix AFX Limb Extension Endograft Recall for Type III Endoleaks
FDA (Devices) · 2018-10-10
- ModerateEndologix AFX2 Endovascular AAA System Recall for Updated Endoleak Information
FDA (Devices) · 2017-01-25
Same hazard · documentation update
See all →- LowPhilips S4-1 ultrasound transducer labelling updated to define useful life
FDA (Devices) · 2026-04-01
- LowPhilips 3D6-2 ultrasound transducer labelling updated to define useful life
FDA (Devices) · 2026-04-01
- LowPhilips OMNI III TEE transducer labelling updated to define useful life
FDA (Devices) · 2026-04-01
- LowPhilips Mini Multi TEE transducer labelling updated to define useful life
FDA (Devices) · 2026-04-01
- LowPhilips X7-2 ultrasound transducer labelling updated to define useful life
FDA (Devices) · 2026-04-01